Page 16 - Buzzing Stock

Shipping Corporation of India share falls 4% on weak Q4 performance

Shipping Corporation of India's profit dropped 19 per cent to Rs 307 crore in Q4FY24, from 380 crore in Q4FY23

Astral shares crack 5% on sluggish Q4 show; PAT, margins take beating

On Friday, Astral, a manufacturer of PVC pipes and plastic products, posted a decline of 11.7 per cent year-on-year (YoY) in its net profits

Pfizer share surges 3% on strong Q4 performance

The surge came after the company announced its fourth quarter results of financial year 2024 (Q4FY24) results

Shares of Zee Ent zoom over 5% on delivering profits in Q4, rising revenues

Shares of Zee Entertainment soared up to 5.2 per cent at Rs 141.65 per share on the BSE in Saturday's intraday trade. The hike in the stock prices came after the company delivered a turnaround

JK Paper up 9% on hopes of recovery in FY25; declares Rs 5 dividend

While the paper company posted a weak set of results, the company reportedly said that it expects higher volume growth in the paper and boards segment in the current financial year of 2024-25 (FY25)

Kaynes Tech zooms 14% on robust Q4; stock more-than-doubles in one year

Notably, the stock has zoomed almost 339 per cent from its listing price of Rs 578, and 121 per cent in the last one year

Brokerages bullish on Crompton Greaves post Q4; stock hits 52-week high

On a yearly basis, Crompton Greaves' profit soared 5.5 per cent to Rs 138.4 crore in the March quarter of FY24, from Rs 131 crore in the March quarter of FY23

Quick Heal rises 5% on inking pact with EET Group; up 25% in last 6 months

The surge came following the announcement of a strategic collaboration with Europe's EET Group to bolster its cybersecurity offerings

Pricol shares hit 52-week high on robust March quarter results

The automotive components manufacturer's net profit climbed 39.3 per cent to Rs 41.5 crore in the March quarter of financial year 2024 (Q4FY24)

Titagarh Rail Systems shares zoom 9% on stellar Q4 earnings; profits rise

Titagarh Rail Systems Revenue saw an 8 per cent year on year (YoY) uptick, reaching Rs 1,052.4 crore in Q4FY24 compared to Rs 974.2 crore in Q4FY23

NCC shares surge 7% on strong Q4 performance

The industrial building construction company's net profit increased 25.2 per cent in the fourth quarter of financial year 2024 (Q4FY24) to Rs 239.2 crore

TBO Tek makes strong market debut; lists at 50% premium over issue price

On the NSE, TBO Tek made debut at Rs 1,426 per share, a 55 per cent premium to its issue price of Rs 920

Radico Khaitan stock surges 4% on strong Q4 performance

The company's consolidated revenue from operations stood at Rs 3,894.6 crore in Q4FY24, as opposed Rs 3,375.4 crore in Q4FY23

Andhra Paper stock split: Board approves split in 1:5 ratio; stock falls 4%

The fall came a day after the company announced its March quarter results for FY24 (Q4FY24), along with stock-split and dividend announcement

CE Info Systems shares rise 6% on strong Q4 performance

The software products company's net profit zoomed 36 per cent on a year-on-year (Y-o-Y) basis to Rs 38 crore in the March quarter of FY24, from Rs 28 crore in the March quarter of FY23

Jindal Steel and Power shares hit 52 week high on strong Q4 performance

The surge came after the company announced a strong set of quarter-ending March of financial year 2024 (Q4FY24) results

Alembic ltd zooms 13% on strong Q4 performance; net profit rises by 425%

The total consolidated income of Alembic rose by 30.7 per cent at Rs 51 crores in the March quarter of FY24 as against Rs 39 crores in the corresponding quarter of the previous fiscal year

Morgan Stanley, CLSA bullish on Zomato after solid Q4, check target prices

On the bourses, Zomato was trading 1.39 per cent lower at Rs 191 per share, at 9:42 AM. By comparison, S&P BSE Sensex was up 0.11 per cent at 72,853.25 levels

Neuland Labs plunges over 14% on weak Q4 performance; Profit, margins drop

Neuland Labs total income fell by 6 per cent year on year (YoY) to Rs 390 crore in Q4FY24 as against Rs 415 crore in Q4FY23

Strides Pharma rises 3% after US FDA approves Hypocalcemia drug

The rise came after the company announced that the United States Food and Drug Administration (US FDA) has approved its Sevelamer carbonate tablets 800 mg